Empaglimet 12.5/850mg Tablet

Empaglimet 12.5/850mg Tablet is a combination medication containing empagliflozin & metformin HCI. It is formulated to manage type 2 diabetes mellitus by helping to control blood sugar levels. Empagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by promoting the excretion of glucose through the kidneys. Metformin HCI is a biguanide medication that helps to decrease glucose production in the liver and improve insulin sensitivity in the body.

Ingredients:

• Empagliflozin
• Metformin HCI

Uses:

• Blood Sugar Control: Empaglimet 12.5/850mg Tablet is used to manage blood sugar levels in individuals with type 2 diabetes mellitus.
• Combination Therapy: This medication is prescribed when treatment with empagliflozin or metformin alone is not sufficient to control blood glucose levels adequately.
• Improved Insulin Sensitivity: Metformin HCI helps to increase insulin sensitivity and decrease glucose production in the liver.
• Glucose Excretion: Empagliflozin promotes the excretion of glucose through the kidneys, leading to decreased blood sugar levels.

Dosage:

• The dosage of Empaglimet 12.5/850mg Tablet should be determined by a healthcare professional based on individual patient factors, including medical history and current blood sugar levels.
• It is usually taken orally with a meal, as directed by the healthcare provider.
• It is important to follow the prescribed dosage regimen and not exceed the recommended dose.

Precautions:

• This medication may cause side effects such as hypoglycemia (low blood sugar) or urinary tract infections. Patients should be monitored for these effects.
• It is important to inform the healthcare provider about any other medications, supplements, or medical conditions before starting Empaglimet 12.5/850mg Tablet.
• Individuals with kidney or liver problems should use this medication with caution and may require dose adjustments.
• Pregnant or breastfeeding women should consult a healthcare professional before using this medication.
• Alcohol consumption may increase the risk of lactic acidosis when taking metformin HCI.
• Patients should follow a healthy diet and exercise regimen as directed by their healthcare provider while taking this medication.

Storage:

• Store Empaglimet 12.5/850mg Tablet at room temperature, away from moisture and heat.
• Keep it out of reach of children and pets.
• Do not use the medication if it has expired or if the packaging is damaged.